ArticleMolecular neurobiology2026
Time-Resolved Oxidative Stress and Apoptosis in Murine Retina under Acute Hypobaric Hypoxia with Parallel Activation of the LIF-JAK-STAT3 Axis.
Article in Molecular neurobiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Targeting P2X7R Protects the Retina Against High-Altitude Hypoxia via NLRP3-Mediated Pyroptosis Suppression.Molecular neurobiology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
High-altitude retinopathy (HAR) arises under acute hypobaric hypoxia (AHH), yet the temporal coupling of oxidative stress, apoptosis and cytokine signaling in the retina remains unclear. We exposed healthy male C57BL/6 mice to a hypobaric chamber (≈5,000 m) for 2-72 h, with normoxic controls at 1,500 m (n = 3 eyes/group). Haematoxylin-eosin sections quantified total and laminar thickness; at 24 h, bulk RNA-seq profiled transcripts. Reactive oxygen species (ROS) were assayed by dihydroethidium, and Western blotting/immunofluorescence evaluated Bax, Bcl-2/Bcl-xL, cleaved caspase-3, cytochrome c, poly(ADP-ribose) polymerase-1, tumour necrosis factor-α, phosphorylated Janus kinase-1 (p-JAK1), phosphorylated signal transducer and activator of transcription-3 (p-STAT3), leukemia inhibitory factor (LIF) and LIF receptor (LIFR). Total retinal thickness increased from 173.10 ± 0.36 μm (control) to 227.99 ± 0.33 μm at 24 h and 234.61 ± 0.39 μm at 72 h, with concordant GCL/INL/ONL thickening. RNA-seq showed enrichment of hypoxia/oxidative-stress, apoptotic, and JAK-STAT pathways with Lif/Lifr up-regulation. ROS rose from 12 h and peaked at 72 h (p < 0.05). Pro-apoptotic indices (Bax/Bcl-2, Bax/Bcl-xL, cleaved caspase-3/total) and cytochrome c, PARP-1, and TNF-α increased with exposure. p-JAK1 rose from 12 to 72 h, whereas p-STAT3 peaked at 48 h and remained elevated at 72 h. LIF/LIFR protein accumulated from 2-72 h (48 h apex). These time-resolved data reveal progressive oedema with sustained oxidative burden and a LIF-JAK1-STAT3 activation peak, suggesting a therapeutic window in AHH-induced retinal injury.
Indexed as
Identifiers
41543620What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.